RHYTHM PHARMACEUTICALS, INC.·4

Feb 11, 9:34 PM ET

Manning Linda Shapiro 4

4 · RHYTHM PHARMACEUTICALS, INC. · Filed Feb 11, 2022

Insider Transaction Report

Form 4
Period: 2022-02-09
Manning Linda Shapiro
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-09+75,00075,000 total
    Exercise: $6.80Exp: 2032-02-08Common Stock (75,000 underlying)
  • Award

    Restricted Stock Units

    2022-02-09+12,50012,500 total
    Common Stock (12,500 underlying)
Footnotes (3)
  • [F1]The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F3]The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

Documents

1 file
  • 4
    tm226394-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT